<p>A, Graph of neurosphere forming assay indicating the relative neurosphere numbers of C1-treated patient-derived GBM samples (GBM146, GBM157, and GBM206) and normal neural progenitors (16wf). B, CD133(+) and (−) cells, separated from GBM157-derived sphere cultures, were treated with 1 μM C1 or DMSO (control) under the identical serum-free conditions for 48 hours. The effect on CD133(+) cells was assessed by the neurosphere number per well, and the effect on CD133(−) cells was assessed by the % change of the total cell number in comparison to the control sample. C, Schematic showing organotypic slice cultures explanted GBM tissues and treated with C1 or DMSO (control) for 16 hours and evaluated with H&E, Ki67, and Nestin staining. D, Immun...
a) Adult bone marrow derived macrophages were isolated and pre-treated for 1 hour with C1 (0.025 μM,...
Glioblastoma multiforme (GBM) is the most aggressive, infiltrative brain cancer. Tumour recurrence i...
Aims and Background: Glioma is difficult to treat and despite advances, outcomes remain poor and new...
<p>A, Proliferation assays on two glioblastoma cell lines (U87 and U251). U87 and U251 cells were tr...
<p><b>A</b>, Treatment of primary hippocampal cultures with DCM (conditioned medium harvested from G...
a) The metabolic activity of primary cultured neonatal microglia, primary cultured neonatal astrocyt...
<p><b>a.</b> Serum-differentiated GSC23, GG1, GG9, GG14 and GG16 (primary) neurospheres (Nsp) revert...
<p>(A) Phase contrast image of neurospheres at passage 3 from the cerebral cortex of E14.5 C57BL/6 m...
(a) Stitched image of coronal section showing microglial density at steady state (Ctrl), after 2 wee...
<p>Neurospheres were immunostained with Ki67, nestin, DCX and GFAP antibodies to determine the effec...
<p><b>A,</b> Representative immunostaining of GFAP in the enriched astrocytic culture. <b>B–E</b>, a...
a) Microglia were stimulated for 24 hours with 1 μg/mL LPS before being treated with 2.5 μM C1 (in r...
<p>(A) Summary graph of the viability of U251 and U87 GBM cells pre-treated with radiation (4 Gy) an...
Figure S10. Peripheral pre-treatment with IL12 antibody partially eliminates the CCP-mediated M1-lik...
<p>A. Representative images of brain sections depicting the expression of cell cycle markers in the ...
a) Adult bone marrow derived macrophages were isolated and pre-treated for 1 hour with C1 (0.025 μM,...
Glioblastoma multiforme (GBM) is the most aggressive, infiltrative brain cancer. Tumour recurrence i...
Aims and Background: Glioma is difficult to treat and despite advances, outcomes remain poor and new...
<p>A, Proliferation assays on two glioblastoma cell lines (U87 and U251). U87 and U251 cells were tr...
<p><b>A</b>, Treatment of primary hippocampal cultures with DCM (conditioned medium harvested from G...
a) The metabolic activity of primary cultured neonatal microglia, primary cultured neonatal astrocyt...
<p><b>a.</b> Serum-differentiated GSC23, GG1, GG9, GG14 and GG16 (primary) neurospheres (Nsp) revert...
<p>(A) Phase contrast image of neurospheres at passage 3 from the cerebral cortex of E14.5 C57BL/6 m...
(a) Stitched image of coronal section showing microglial density at steady state (Ctrl), after 2 wee...
<p>Neurospheres were immunostained with Ki67, nestin, DCX and GFAP antibodies to determine the effec...
<p><b>A,</b> Representative immunostaining of GFAP in the enriched astrocytic culture. <b>B–E</b>, a...
a) Microglia were stimulated for 24 hours with 1 μg/mL LPS before being treated with 2.5 μM C1 (in r...
<p>(A) Summary graph of the viability of U251 and U87 GBM cells pre-treated with radiation (4 Gy) an...
Figure S10. Peripheral pre-treatment with IL12 antibody partially eliminates the CCP-mediated M1-lik...
<p>A. Representative images of brain sections depicting the expression of cell cycle markers in the ...
a) Adult bone marrow derived macrophages were isolated and pre-treated for 1 hour with C1 (0.025 μM,...
Glioblastoma multiforme (GBM) is the most aggressive, infiltrative brain cancer. Tumour recurrence i...
Aims and Background: Glioma is difficult to treat and despite advances, outcomes remain poor and new...